Research ExplorerPublications[Presentation of the cooperative study COALL-80 on treatment...

[Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]

Standard

[Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]. / Winkler, K; Matzke, E; Caspers, S; Erttmann, Rudolf; Grosch-Wörner, I; Kabisch, H; Müller, J; Landbeck, G.

In: KLIN PADIATR, Vol. 193, No. 3, 3, 1981, p. 155-158.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Winkler, K, Matzke, E, Caspers, S, Erttmann, R, Grosch-Wörner, I, Kabisch, H, Müller, J & Landbeck, G 1981, '[Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]', KLIN PADIATR, vol. 193, no. 3, 3, pp. 155-158. <http://www.ncbi.nlm.nih.gov/pubmed/6943388?dopt=Citation>

APA

Winkler, K., Matzke, E., Caspers, S., Erttmann, R., Grosch-Wörner, I., Kabisch, H., Müller, J., & Landbeck, G. (1981). [Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]. KLIN PADIATR, 193(3), 155-158. [3]. http://www.ncbi.nlm.nih.gov/pubmed/6943388?dopt=Citation

Vancouver

Winkler K, Matzke E, Caspers S, Erttmann R, Grosch-Wörner I, Kabisch H et al. [Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]. KLIN PADIATR. 1981;193(3):155-158. 3.

Bibtex

@article{d5fe5f1080e34c02818edd3a33eee474,
title = "[Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]",
abstract = "The cooperative study COALL-80 is derived from the BFM-78-study. The aim of the study is a reduction of the initial therapy-morbidity and -mortality without loss of efficacy by omitting asparaginase from the four drug-induction regimen and interposing it between induction- and CNS-therapy phase. The expected two years disease free survival rate of a pilot study will be 82%. This finding is hitherto comparable with the BFM-study results.",
author = "K Winkler and E Matzke and S Caspers and Rudolf Erttmann and I Grosch-W{\"o}rner and H Kabisch and J M{\"u}ller and G Landbeck",
year = "1981",
language = "Deutsch",
volume = "193",
pages = "155--158",
journal = "KLIN PADIATR",
issn = "0300-8630",
publisher = "Georg Thieme Verlag KG",
number = "3",

}

RIS

TY - JOUR

T1 - [Presentation of the cooperative study COALL-80 on treatment of childhood ALL (author's transl)]

AU - Winkler, K

AU - Matzke, E

AU - Caspers, S

AU - Erttmann, Rudolf

AU - Grosch-Wörner, I

AU - Kabisch, H

AU - Müller, J

AU - Landbeck, G

PY - 1981

Y1 - 1981

N2 - The cooperative study COALL-80 is derived from the BFM-78-study. The aim of the study is a reduction of the initial therapy-morbidity and -mortality without loss of efficacy by omitting asparaginase from the four drug-induction regimen and interposing it between induction- and CNS-therapy phase. The expected two years disease free survival rate of a pilot study will be 82%. This finding is hitherto comparable with the BFM-study results.

AB - The cooperative study COALL-80 is derived from the BFM-78-study. The aim of the study is a reduction of the initial therapy-morbidity and -mortality without loss of efficacy by omitting asparaginase from the four drug-induction regimen and interposing it between induction- and CNS-therapy phase. The expected two years disease free survival rate of a pilot study will be 82%. This finding is hitherto comparable with the BFM-study results.

M3 - SCORING: Zeitschriftenaufsatz

VL - 193

SP - 155

EP - 158

JO - KLIN PADIATR

JF - KLIN PADIATR

SN - 0300-8630

IS - 3

M1 - 3

ER -